当前位置: X-MOL 学术Biomaterials › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Combination antitumor immunotherapy with VEGF and PIGF siRNA via systemic delivery of multi-functionalized nanoparticles to tumor-associated macrophages and breast cancer cells
Biomaterials ( IF 14.0 ) Pub Date : 2018-09-11 , DOI: 10.1016/j.biomaterials.2018.09.017
Yudong Song , Cui Tang , Chunhua Yin

Given that vascular endothelial growth factor (VEGF) and placental growth factor (PIGF), over-expressed in breast cancer cells and M2-like tumor-associated macrophages (M2-TAMs) within tumor microenvironment (TME), work synergistically and independently in mediating tumor progression and immunosuppression, combinatorial immune-based approaches targeting them are expected to be a potent therapeutic modality for patients. Here, polyethylene glycol (PEG) and mannose doubly modified trimethyl chitosan (PEG = MT) along with citraconic anhydride grafted poly (allylamine hydrochloride) (PC)-based nanoparticles (NPs) (PEG = MT/PC NPs) with dual pH-responsiveness were developed to deliver VEGF siRNA (siVEGF)/PIGF siRNA (siPIGF) to both M2-TAMs and breast cancer cells for antitumor immunotherapy. With prolonged blood circulation and intelligent pH-sensitivity, PEG = MT/PC NPs were highly accumulated in tumor tissues and then internalized in M2-TAMs and breast cancer cells via mannose-mediated active targeting and passive targeting, respectively. With the charge-reversal of PC, PEG = MT/PC NPs presented effective endosomal/lysosomal escape and intracellular siRNA release, resulting in efficient gene silencing. Due to the synergism between siVEGF and siPIGF in anti-proliferation of tumor cells and reversal of the TME from pro-oncogenic to anti-tumoral, PEG = MT/PC/siVEGF/siPIGF NPs (PEG = MT/PC/siV-P NPs) exerted robust suppression of breast tumor growth and lung metastasis. This combination strategy may provide a promising alternative for breast cancer therapy.



中文翻译:

通过将多功能纳米颗粒系统递送至肿瘤相关的巨噬细胞和乳腺癌细胞,将VEGF和PIGF siRNA联合用于抗肿瘤免疫治疗

鉴于血管内皮生长因子(VEGF)和胎盘生长因子(PIGF)在肿瘤微环境(TME)内的乳腺癌细胞和M2样肿瘤相关巨噬细胞(M2-TAMs)中过表达,因此在介导中起协同作用和独立作用肿瘤进展和免疫抑制,针对它们的基于组合免疫的方法有望成为患者的有效治疗手段。在这里,聚乙二醇(PEG)和甘露糖双修饰的三甲基壳聚糖(PEG = MT)以及基于柠康酸酐接枝的聚(烯丙胺盐酸盐)(PC)的纳米颗粒(NPs)(PEG = MT / PC NPs)具有双重pH响应已开发出可将VEGF siRNA(siVEGF)/ PIGF siRNA(siPIGF)递送至M2-TAM和乳腺癌细胞以进行抗肿瘤免疫治疗的方法。分别通过甘露糖介导的主动靶向和被动靶向。通过PC的电荷逆转,PEG = MT / PC NPs表现出有效的内体/溶酶体逃逸和细胞内siRNA释放,从而导致有效的基因沉默。由于siVEGF和siPIGF在肿瘤细胞的抗增殖以及TME从致癌性转变为抗肿瘤性方面的协同作用,PEG = MT / PC / siVEGF / siPIGF NPs(PEG = MT / PC / siV-P NPs )强烈抑制了乳腺肿瘤的生长和肺转移。这种联合策略可能为乳腺癌治疗提供有希望的替代方法。

更新日期:2018-09-11
down
wechat
bug